We’ve been operating on the cutting edge of the life sciences and pharmaceutical fields for over two decades.
Part of that process involves active participation in the larger scientific community, and this page serves as the repository for any recent news and publications from the Brains On-Line team.
The Science behind Brains On-Line: "Can you really do that?”
That was the #1 question from those who encountered our booth in San Diego, and poster sessions. With that in mind, we wanted to make the best bits of that information available to you, our friends and clients, for further reference.
Brains On-Line is pleased to introduce Encepharm®, a new addition to the Brains On-Line group of companies.
The acquisition of Encepharm enables Brains On-Line to offer innovative, translational solutions from early discovery through to late-stage development in Non-Human Primates (NHPs).
Brains On-Line, is pleased to announce our expanded range of services to include behavioral assays covering the key behavioral domains related to cognition, schizophrenia, anxiety/depression, Parkinson’s disease and phenotypic behavioral studies.
Brains On-Line is an established preclinical CRO specializing in in vivo pharmacology and exploratory CNS safety evaluation.
We carry out proof of principle, PK/PD, drug interactions/metabolism studies, in both rodents and NHP.
Brains On-line presents posters at the annual Society for Neuroscience meeting entitled ‘Adenosine as a parameter to determine the quality of the rapid microwave fixation of rat brain for the determination of cAMP and cGMP in brain tissue’ and ‘Preclinical development of a novel class of competitive inhibitors of the Glycine Transporter-1 (GlyT-1) for the treatment of cognitive deficits’.